Metastatic colorectal cancer: irinotecan plus infusional, bolus or oral fluoropyrimidines as first-line treatment

Affiliations

Comment

David J Kerr. Nat Clin Pract Oncol. 2008 May.

. 2008 May;5(5):250-1.

doi: 10.1038/ncponc1108. Epub 2008 Apr 1.

¹ Department of Clinical Pharmacology, University of Oxford, Oxford, UK. david.kerr@clinicalpharmacology.oxford.ac.uk

No abstract available

Comment on

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
Fuchs CS, Marshall J, Mitchell E, Wierzbicki R, Ganju V, Jeffery M, Schulz J, Richards D, Soufi-Mahjoubi R, Wang B, Barrueco J. Fuchs CS, et al. J Clin Oncol. 2007 Oct 20;25(30):4779-86. doi: 10.1200/JCO.2007.11.3357. J Clin Oncol. 2007. PMID: 17947725 Clinical Trial.